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Designing an electronic blood-borne virus risk alert to improve uptake of testing 
Abstract 
The primary aim of the current study was to test the effect of the presentation design 
of a test alert system on healthcare workers’ decision-making regarding blood-borne 
virus (BBV) testing.  The secondary aim was to determine healthcare workers’ 
acceptance of the system.  An online survey used a within-subjects research design 
with four design factors as independent variables.  The dependent variable was 
clinical decision.  Ten realistic descriptions of hypothetical patients were presented to 
participants who were asked to decide whether to request BBV testing. The effect of 
a pre-set course of action to request BBV testing was significant when additional 
information (cost-effectiveness, date of last BBV test or risk assessment) was not 
presented, with a 16% increase from 30% to 46% accept decisions.  When risk 
assessment information was presented without a pre-set course of action, the effects 
of cost-effectiveness (27% increase) and last test date (23% decrease) were 
significant.  The main reason for declining to test was insufficient risk.  Healthcare 
workers’ acceptance of the test alert system was high and resistance was low.  We 
make recommendations from the results for the design of a subsequent real-world 
trial of the test alert system.   
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1. Introduction 
1.1. Background 
Late diagnosis of HIV, hepatitis B and hepatitis C, the blood-borne viruses (BBV), 
remains common in the UK despite national guidelines and other efforts to increase 
BBV-testing amongst those at risk of infection1,2.  Increased testing in primary care 
and certain hospital settings has been prioritised, particularly for HIV3,4.  However, in 
many areas of the country testing rates have remained low, and late diagnosis is 
widespread: in around 40% of new HIV diagnoses nationally and over 50% in some 
parts of north-east England5,6,7,8.  There is often a reluctance amongst GPs, hospital 
doctors and other health-care workers (HCWs), especially those less experienced in 
seeing and managing BBVs, to offer BBV tests as recommended in national 
guidelines9,10,11.  This is due to various reasons, including misconceptions around the 
process of consent for testing and a lack of appreciation of patients’ risk factors.  
HIDES-1 and other studies have found that patients presenting with certain indicator 
conditions have an undiagnosed HIV prevalence > 0.1%, where screening is cost-
effective12,11.  Hence targeted HIV testing amongst patients with identified risk factors 
and indicator conditions is likely to be cost-effective and lead to earlier diagnosis in 
those with undiagnosed infections, even in lower-prevalence areas. 
Efforts to increase testing for these BBV infections in primary and secondary care 
using standard or opt-out processes have mostly had limited success or have 
required significant resources to maintain high testing rates13,14,15.  One recent 
approach in accident-and-emergency departments, the ‘Going Viral’ campaign had 
some success, but still requires significant staff input to maintain high testing rates16.  
New approaches to improving rates of BBV-testing are needed.  Electronic patient 
record (EPR) systems are universally used in primary care, and many areas of 
secondary care.  Over recent years, these systems have allowed development of 
clinical decision support algorithms to guide clinical management, including the 
choice of tests and highlighting abnormal results16,17.  Studies, however, have 
demonstrated the importance of usability and the involvement of users in their 
development to ensure the systems work effectively18,19,20.  Such systems provide an 
opportunity to prompt HCWs to perform BBV tests where pathology and EPR data 
(such as patient demographics and clinical codes) indicate the patient may be at 
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higher risk of undiagnosed BBV infection, ideally at the point of ordering tests during 
the HCW-patient interaction.   
Critical to the success of such an application is the way the alert is displayed and 
how it interacts with a clinician, particularly during the clinician-patient interaction.  
Various studies have identified design factors that are important in the design of 
such systems and alerts to ensure HCWs view the advice, accept it when 
appropriate and do not succumb to ‘alert fatigue’.  Positive predictive factors include 
quality of display, alert priority level and level of detail of the advice given21.  
Moreover, the position of an alert was a significant predictor of acceptance of the 
alert advice, with higher acceptance for alerts at the top of the page than those at the 
bottom22.  The frequencies of alerts per encounter and repeated reminders may also 
predict acceptance, although the literature shows a mixed effect, with one study 
showing reduced acceptance of the alert advice23 whilst another shows increased 
acceptance21; reduced acceptance may indicate alert fatigue, but increased 
acceptance may be due to increased familiarity.  Furthermore, in drug-drug 
interaction alerts, trust cues (information that suggests trustworthiness, e.g. 
endorsement from the head of department) influenced alert acceptance24. 
1.2. Study aims 
Given the importance of an alert application’s information display and interaction with 
clinicians, the primary aim of the current study was to test the effect of the 
presentation design of a test alert system on HCWs’ decision-making regarding 
BBV-testing.  Given the importance of HCWs’ acceptance of new technology in the 
workplace25,26, the secondary aim was to determine their acceptance of BBV alerts.  
We address the following research questions.   
1 What is the effect of pre-selection of decision on decision-making? 
2 What is the effect of the data of the last BBV test? 
3 What is the effect of cost-effectiveness information? 
4 What is the effect of risk assessment information? 
5 What is the level of acceptance of BBV-testing? 
6 How does acceptance vary by HCW characteristics? 
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2. Methods 
2.1. Research design 
A within-subjects research design (Table 1) with four independent variables was 
used: pre-selection of decision (decision to accept the advice to order a BBV test 
pre-selected or not pre-selected), presentation of the date of the last BBV test 
(present or absent), presentation of cost-effectiveness information (present or 
absent) and risk assessment presentation on request (present or absent).  The 
dependent variable was decision (accept/reject). 
2.2. Participants 
Participants were recruited through the North East and North Cumbria Primary Care 
Research Network. They were compensated for their time by a fixed payment of a £5 
voucher.  Participants were 79 HCWs (60 general practitioners [GPs] and 17 nurse 
practitioners and 2 others), 54 female and 25 male.  Mean age was 44 (SD = 9.22). 
2.3. Materials, equipment and procedure 
Realistic descriptions of 10 hypothetical patient scenarios were developed (see 
online supplementary material), with the patient presenting to an HCW, and each 
patient representing one cell in the research design (Table 1).  The patients had 
varying presentations that were not clearly related to typical presentations of HIV 
infection.  These were presented as screenshots of the BBV prompt with an EPR 
system screen in the background. 
Based on the description, in an online survey HCWs were asked to decide whether 
to request BBV-testing.  Presentations 1-8 allowed an initial choice of accept, reject 
or request more information.  If the choice was ‘request more information’, risk 
assessment information was presented; the final choice options were then to accept 
or reject.  Presentations 9 and 10 only allowed a final choice of accept or reject, 
without additional information. 
Further questions measured additional consultation time, preference for number of 
tests included in the prompt, acceptance of and resistance to using the prompt 
system, preference for duration of prompt suppression after previous rejection by 
HCW or patient and preference for prompt presentation.  A soft prompt shows a 
patient’s elevated risk without requiring a HCW to respond, but a hard prompt does 
require a response.  Acceptance and resistance of the prompt system was measured 
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each with a 7-point Likert scale item adapted from previous research27,28.  In 
addition, reasons for rejecting the advice to order a BBV test in response to the 
prompt were recorded. 
2.4. Data analysis 
The design required two data analyses of HCWs’ decision regarding testing for BBV: 
1 2(pre-selection of decision)×2(risk assessment information) analysis, with date of 
last BBV test and cost-effectiveness both absent (Presentations and 4, 8 and 9-
10);  
2 2(pre-selection of decision)×2(last test date)×2(cost-effectiveness) analysis, with 
additional information present (Presentations 1-8).  In Presentations 1-8, both an 
initial decision (accept, request further information or reject) and a final decision 
(accept or reject) were available for analysis; if the initial decision was to accept 
or reject then the final decision and the initial decision were the same.  In 
Presentations 9-10, only a final decision (accept or reject) was available for 
analysis. 
The clinical decision was analysed with generalized mixed-effects binary logistic 
regression models, including random intercept and participant as a random factor.  
Other outcomes were analysed with descriptive statistics, confidence intervals and 
chi square tests.  Open questions were analysed with thematic analysis. 
3. Results 
3.1. Aim 1: the effect of presentation design on healthcare workers’ decision-
making 
3.1.1. Final decision by pre-selection of decision and risk assessment 
Pre-selection of decision.  The effect of pre-selection of decision (‘accept’ pre-
selected or not) was positive (more ‘accept’ decisions), when neither the date of the 
last BBV test, nor cost-effectiveness information nor risk assessment information 
was presented (Table 2/Panel A; Figure 1). 
Pre-selection of decision and risk assessment.  When risk assessment information 
was available, the interaction effect of pre-selection and risk assessment was 
significant (Table 2/Panel B Figure 1).  Specifically, the positive effect of preselection 
was stronger when the information was not available. 
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3.1.2. Analysis of final decision by pre-selection of decision, last-test date information 
and cost-effectiveness information 
As the initial decision was predominantly ‘request more information’ (77% of 
responses), the final decision was analysed. This was done by pre-selection of 
decision (‘accept’ pre-selected or not), date of last BBV test (presented or not) and 
cost-effectiveness information (presented or not).   
Significant were the following effects: the interactions of pre-selection of decision and 
date of last BBV test and of pre-selection and cost-effectiveness, as well as the main 
effects of date and cost-effectiveness (Table 3/Panel A; Figure 2). 
In simple-effect analysis for the conditions without pre-selection of decision (Table 
3/Panel B), the main effect of cost-effectiveness was significant, with more accept 
decisions when cost-effectiveness information was presented.  The main effect of 
date of the last BBV test was also significant, with fewer accept decisions when the 
date was presented. 
In simple-effect analysis for the conditions with pre-selection of decision (Table 
3/Panel C), the effect of cost-effectiveness was significant, with fewer accept 
decisions when cost-effectiveness information was presented. 
3.1.3. Reasons for not requesting a BBV test 
On the initial decision, participants gave various reasons for not requesting a BBV 
test (rejecting the BBV test prompt) at the time of a consultation during which a BBV 
prompt would appear.  The main reason was that insufficient risk had been identified 
(20 responses).  Other reasons included discussing with the patient before test-
ordering (8), a lack of time (7), obtaining further risk information (5) and doing other 
tests or testing elsewhere (5). 
On the final decision, the following reasons were given (72 responses in total).  The 
main reason was discussing with the patient, with shared decision-making and 
consent as major considerations (26 responses).  Other reasons included doing 
other tests first (15), obtaining further risk information (8), first asking a GP to review 
BBV-testing (8 responses, all from nurses), precedence given to the presenting 
problems or symptoms during the consultation rather than to BBV-testing (7) and 
offering the patient BBV-testing (instead of accepting the prompt) (7). 
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3.2. Aim 2: healthcare workers’ acceptance of the BBV alert system 
3.2.1. Additional consultation time 
Mean estimated additional consultation time was 3.71 minutes (see also Table 4).  
This time was positively correlated with years of work experience (r = 0.31, p = 
0.007).  Moreover, nurses estimated the additional consultation time higher than GPs 
(Table 4). 
3.2.2. Preference for number of tests 
A statistically significant 67% of HCWs preferred a single test (for all 3 BBVs) rather 
than multiple tests (i.e. several different alerts for individual BBVs), chi square (1) = 
9.23, p = 0.002. 
3.2.3. Acceptance and resistance 
Overall, acceptance of the BBV alerts was above average (neutral scale value of 3): 
(Table 4).  Overall, resistance to the BBV alerts was below average (neutral scale 
value of 3) (Table 4). 
3.2.4. Preference of prompt presentation 
Preference of prompt presentation was predominantly (90%) soft (user can dismiss 
the prompt). 
3.2.5. Duration of prompt suppression after a BBV-testing has been declined 
previously 
Preference of the duration of prompt suppression after a HCW has declined to order 
a BBV test was predominantly 6 months (43% of responses) or 1 year (48%).  
Preference for the duration of prompt suppression after a patient has refused a BBV 
test was predominantly 1 year (53% of responses), followed by 6 months (18%) and 
2 years (15%). 
4. Discussion 
4.1. Presentation design 
The effect of pre-selection of decision was positive and significant when additional 
information (cost-effectiveness, last test date or risk assessment) was not presented, 
with a 16% increase from 30% to 46% accept decisions and an odds ratio of 1.92.  
This result can be explained with the concept of nudge29, a (deliberate) change in the 
environment that influences choice behaviour.  Specifically, the result is consistent 
with other evidence of the power of pre-selected options (‘default nudges’) to 
positively influence behaviour in other domains30,31. 
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When risk assessment information was presented and without pre-selection of 
decision, the effects of cost-effectiveness (27% increase) and last test date (23% 
decrease) were significant.  In support of our findings, uncertainty about cost-
effectiveness has been identified as a barrier to the use of point-of-care tests32.  
However, the effect of cost-effectiveness was negative with pre-selection of decision; 
this indicates the importance of carefully considering the combination of design 
factors (such as the presentation of cost-effectiveness information) in alert system 
design.  The negative effect of date of the last BBV test may be because presence of 
the information suggests that the patient has already been tested.  However, this 
effect potentially indicates a lack of knowledge in HCWs about the importance of 
regular testing, based on the available data from a patient record and knowledge of 
their risk factors.  Nevertheless, if new patient data after the date of the last previous 
test trigger the test prompt then BBV-testing should be re-considered, as the trigger 
may not have been present at the date of last testing.  Education of HCWs will be 
needed to improve their knowledge and decision-making in this respect.  The 
predominant reason (71%) for declining to test for BBV was insufficient risk.  In 
support of this finding, risk perception has been identified as a determinant of 
decision-making in models of risk decision-making33 and in protection motivation 
theory34, according to which both people’s threat appraisal (including risk perception) 
and their coping appraisal are drivers of their motivation to protect their health.  
Therefore, as risk perception of BBV infection for a patient decreases, the 
willingness to order tests for that patient may decrease as well.  Another reason for 
declining to test was that HCWs first wanted to discuss BBV test ordering with the 
patient.  This highlights the importance that HCWs attach to shared decision-making 
in their consultations with patients35. 
4.2. Healthcare workers’ acceptance of the test prompt system 
The mean estimated additional consultation time was 3.71 minutes.  Given the 
typical time of 10 minutes being available for a primary-care consultation, the rated 
high acceptance of and low resistance to prompt system seems surprising.  This is 
because responding to the prompt would take up 37% of their consultation time.  
Perhaps our HCW-participants did not take into account the additional consultation 
time in their ratings.  Alternatively, they may have considered the additional time 
justified in terms of the potential benefit of ordering the test.  According to previous 
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research, primary-care HCWs accept two additional minutes of consultation to use a 
computerised decision-support system in their patient consultations, but not five 
minutes26.  Potential reasons for the long additional estimated time include a lack of 
familiarity with opt-out testing for BBVs, an initial lack of familiarity with the BBV test 
prompt and stigma associated with HIV testing.  Measures to reduce the time to two 
minutes could include staff training in the use of opt-out HIV testing and the BBV test 
prompt system.  In any case, it is important to establish the actual additional 
consultation time, if any, to ascertain whether using the prompt system is realistic 
within the constraints of HCWs’ patient consultations. 
The finding that more experienced HCWs gave higher estimates may indicate that 
they are more realistic in terms of the time required to make a test order decision or 
that they spend more time communicating information and sharing decision-making 
with patients.  Moreover, the consultation time and potentially also additional time 
also depends on HCWs’ information-sharing style when using electronic health 
records36. 
A majority of HCWs (67%) preferred a single BBV test over separate tests.  
Furthermore, the predominant preference (90%) for prompt presentation was soft.  
Both these findings are consistent with the behavioural principle of aversion to 
complexity in order to reduce cognitive and choice overload37.  Even though the 
HCWs preferred a soft prompt, there may be a case for having a hard prompt in 
patients with substantially higher risks identified.  As an alternative to prompts, 
dynamically annotated visualizations (DAVs) are similar to our soft prompt in that 
they are continuously displayed.  DAVs appear alongside the ordering form, provide 
real-time graphical decision support for imaging-ordering, and have been found to be 
beneficial in reducing clinically inappropriate diagnostic imaging orders38.  The 
information is presented without HCWs having to direct their attention to the 
visualization within the display, does not require a response (thereby reducing 
workflow interruptions) and only gives explicit recommendations when the 
algorithm’s confidence is high. 
The acceptance of a BBV test alert system was significantly above average and 
resistance was significantly below average.  The finding of high acceptance in HCWs 
has been explained by factors such perceived ease of use, perceived usefulness, 
compatibility, organisational facilitators, subjective norm and habit39,25.  The findings 
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regarding preferred time interval to re-instate a prompt suggest that HCWs are more 
likely to be flexible in terms of potentially changing their decision to order a test than 
patients.  This may be because they consider the possibility that the patient may 
subsequently develop additional risk factors which make testing a higher priority. 
4.3. Recommendations 
The following recommendations are made from the results of the current study for 
the design of a subsequent real-world trial of the BBV test alert system.   
1 In order to increase the rate of accept decisions, (a) the accept decision should 
be preselected, (b) cost-effectiveness information should be presented if the 
accept decision is not pre-selected, (c) the date of last the BBV test should not be 
presented and (d) if the accept decision is not preselected, then risk information 
should be presented. 
2 A single combined set of BBV tests should be offered. 
3 Alerts should be presented as a soft prompt, but as a hard prompt in patients with 
substantially higher risks identified. 
4 Time interval to re-instate a prompt after previous refusal by HCW or patient 
should be one year.  Future research should analyse reasons why specific 
intervals are preferred and the potential usefulness of a more regular prompt for 
high-risk individuals. 
5. Conclusion 
We have demonstrated the effect of design factors on decision-making for BBV-
testing.  In particular, pre-selection of decision, cost-effectiveness information and 
date of last BBV test were influential variables.  Acceptance of using the BBV test 
prompt was high and resistance to its use was low.  This research provides a basis 
for the development and real-world testing of the BBV test prompt facility within an 
electronic-patient record system that is the subject of our current research. 
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Table 1
Research design
No risk assessment 
presented
Pre-selection of 
decision
P1 P2 P3 P4 P9
No pre-selection         

P5 P6 P7 P8 P10
CEI 
presented
CEI not 
presented
CEI 
presented
CEI not 
presented
Risk assessment presentation on request
Date of last BBV test 
presented
Date not presented
Note . P: presentation. CEI: cost-effectiveness information.  
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Table 2
Decision analysed by pre-selection of decision and risk assessment information
Panel A: pre-selection of decision
Predictor b SE OR z p
Pre-selection of decision -1.10 0.47 0.33 -2.34 0.02
Panel B: pre-selection of decision and risk assessment information
Predictor b SE OR z p
Pre-selection of decision -1.07 0.44 0.34 -2.45 0.01
Risk assessment -0.73 0.43 0.48 -1.68 0.09
Pre-selection by risk assessment 1.55 0.60 4.71 2.24 0.03
Note . Decision coded as 0 = 'accept', 1 = 'decline'.  
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Table 3
Panel A: pre-selection of decision, cost-effectiveness information and date of last BBV test
Predictor b SE OR z p
Pre-selection of decision 0.00 0.44 1.00 0.00 1.00000
Cost-effectiveness information -1.85 0.47 0.16 -3.97 0.00007
Date of last BBV test 2.22 0.53 9.18 4.21 0.00003
Preselection by cost-effectiveness 2.88 0.67 17.87 4.32 0.00002
Pre-selection by date -2.12 0.69 0.12 -3.09 0.00200
Cost-effectiveness by date -0.66 0.68 0.52 -0.97 0.33400
Pre-selection by cost-eff. by date 0.13 0.94 1.14 0.14 0.89200
Panel B: cost-effectiveness information and date of last BBV test (without pre-selection)
Predictor b SE OR z p
Cost-effectiveness information -1.76 0.61 0.17 -2.86 0.00421
Date of last BBV test 1.98 0.73 7.26 2.70 0.00694
Cost-effectiveness by date -0.15 0.83 0.86 -0.19 0.85343
Panel C: cost-effectiveness information and date of last BBV test (with pre-selection) 
Predictor b SE OR z p
Cost-effectiveness information 1.02 0.47 2.77 2.18 0.02910
Date of last BBV test 0.00 0.44 1.00 0.00 1.00000
Cost-effectiveness by date -1.38 0.73 0.25 -1.89 0.05880
Note . Decision coded as 0 = 'accept', 1 = 'decline'.
Decision analysed by pre-selection of decision, date of last BBV test and cost-
effectiveness information
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Outcome 
measure
Mean
Lower limit Upper limit
All healthcare 
workers
3.71 2.92 4.44
Nurse 
practitioners
5.80 3.80 7.69
General medical 
practitioners
3.17 2.43 4.02
3.44 3.24 3.66
2.41 2.20 2.62
Table 4
Healthcare workers’ acceptance of the BBV alert system
Note . Bootstrapped bias-corrected accelerated confidence intervals.
95%-confidence interval
Additional 
consultation time
Acceptance

Resistance              
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Figure 1. Decision by pre-selection of decision and risk assessment information. 
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Figure 2. Decision by pre-selection of decision, cost-effectiveness information and 
last-test date information. 
